logo
Search
  • POA Pharma Scandinavia AB signs distribution agreement with Galen limited.

    POA Pharma Scandinavia AB signs distribution agreement with Galen Limited for marketing and sale of POA Pharma´s metabolic product portfolio in UK and Ireland.

    The market for products defined as Medical Nutrition is a highly competitive but fast growing market all over the world. POA intends to be among the leading companies and adding UK and Ireland to our geographic presence, means that our Products will be available via distributors in more than 40 countries.

    “We are really satisfied having the possibilities to cooperate with Galen in one of Europes most strategic countries regarding Medical nutrition,” says Tina Madsen Sandström, CEO of the POA Group.

    David Bennett, Managing Director of Galen Limited, stated, “We are delighted to have established this partnership with POA Pharma for the distribution of their metabolic product portfolio in the UK and Ireland. These agreements will enable Galen to provide new treatment options for both patients and healthcare professionals and will constitute an important step forward in establishing Galen as a key company within this part of the hospital sector”.  

    About GALEN LIMITED: Galen is a privately owned, specialty Pharmaceutical Company, headquartered in Craigavon (Northern Ireland). The company markets products within the UK, Ireland, Europe and the US in therapy areas such as gastroenterology and pain management. Through acquisitions & established partnerships, Galen now has product sales in 23 countries, and plans to continue expanding its portfolio and presence through selected specialty products and new collaborations on an international basis.

    For press releases and other company information, visit: http://www.galen-pharma.com

    Please contact for further information.

     

    About POA Pharma – The Boutique Healthcare Company: POA Pharma is a market oriented Boutique Healthcare Company present in 9 competence areas with offices in Denmark, Finland, Norway, Sweden and US. The home Market is theNordic countries were POA represents 12 Pharmaceutical producers from 11 countries. Our export is based on POA proprietary products, classified as Food for specific medical Purposes, products that are sold in more than 40 countries.

    For further information, please contact or visit http://www.poapharma.com

     
    Leave a reply →